Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Aino Health ABOSTO:AINO 26 PS Ratio is 1.61 as of Jul. 24, 2026, which is 30% above its 10-year median of 1.24. GuruFocus rates OSTO:AINO with a GF Score™ of 26/100 and a GF Value™ of kr0.13 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 659 Healthcare Providers & Services companies, Aino Health AB ranks worse than 52.05% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Aino Health AB's share price is kr0.193.
Aino Health AB's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was kr0.12. Hence, Aino Health AB's PS Ratio for today is 1.61.
The historical rank and industry rank for Aino Health AB's PS Ratio or its related term are showing as below:
OSTO:AINO'
s PS Ratio Range Over the Past 10 Years
Min: 0.33 Med: 1.24 Max: 3.77
Current: 1.61
During the past 12 years, Aino Health AB's highest PS Ratio was 3.77. The lowest was 0.33. And the median was 1.24.
OSTO:AINO's PS Ratio is ranked worse than 52.05% of 659
companies
in the Healthcare Providers & Services industry
Industry Median: 1.47
vs OSTO:AINO: 1.61
Aino Health AB revenue per share has been in decline for the last 5 years.
During the past 12 months, the average Revenue per Share Growth Rate of Aino Health AB was -30.20% per year.
During the past 3 years, the average Revenue per Share Growth Rate was -22.40% per year.
During the past 5 years, the average Revenue per Share Growth Rate was -32.70% per year.
During the past 10 years, the average Revenue per Share Growth Rate was -22.60% per year.
During the past 12 years, Aino Health AB's highest 3-Year average Revenue per Share Growth Rate was 27.30% per year. The lowest was -39.50% per year. And the median was -24.80% per year.
Back to Basics: PS Ratio
Aino Health AB (OSTO:AINO) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Aino Health AB PS Ratio Related Terms
Aino Health AB PS Ratio Historical Data
* Premium members only.
The historical data trend for Aino Health AB's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Aino Health AB's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aino Health AB PS Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Aino Health AB's PS Ratio distribution charts can be found below:
* The bar in red indicates where Aino Health AB's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Aino Health AB's Share Price of today is kr0.193. Aino Health AB's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.12.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Aino Health AB (OSTO:AINO) has a PS Ratio of 1.61 as of Jul. 24, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Aino Health AB and its competitors. This is 30% above median its historical median of 1.24. Over the past decade, Aino Health AB's PS Ratio has ranged from 0.33 to 3.77. According to the industry distribution chart, Aino Health AB ranks #343 out of 659 companies in the Healthcare Providers & Services industry, placing it in the top 52%.
Is Aino Health AB's PS Ratio too high?
Aino Health AB's current PS Ratio of 1.61 is 30% above median its 10-year median of 1.24. Over the past 10 years, this metric has ranged from a low of 0.33 to a high of 3.77. The Healthcare Providers & Services industry median PS Ratio is 1.47. Aino Health AB's value of 1.61 is 9.5% above this industry median. Based on the distribution chart, Aino Health AB ranks #343 out of 659 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Aino Health AB has a GF Score™ of 26/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Aino Health AB's PS Ratio compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Aino Health AB ranks #343 out of 659 companies for PS Ratio. This places Aino Health AB in the lower half of its industry. The industry median PS Ratio is 1.47. Aino Health AB's value of 1.61 is 9.5% above this benchmark. Historically, Aino Health AB's own PS Ratio has ranged from 0.33 to 3.77 over the past decade. While the company's 10-year median is 1.24 vs. the industry median of 1.47, Aino Health AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Healthcare Providers & Services company?
The median PS Ratio among Healthcare Providers & Services companies is 1.47, based on 659 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Aino Health AB's current PS Ratio of 1.61 is 9.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Aino Health AB and its competitors. For the Healthcare Providers & Services industry, the median PS Ratio is 1.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aino Health AB's current PS Ratio is 1.61, which is 30% above median its own 10-year median of 1.24. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aino Health AB stock overvalued right now?
Based on GuruFocus' analysis, Aino Health AB (OSTO:AINO) is currently considered Significantly Overvalued. The stock's GF Value™ is kr0.13, compared to a current price of kr0.19 — trading 48.5% above its estimated fair value. The current PS Ratio is 1.61, which is 30% above median its 10-year median of 1.24 and 9.5% above the Healthcare Providers & Services industry median of 1.47. Aino Health AB's overall GF Score™ is 26/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Aino Health AB (OSTO:AINO), the current PS Ratio is 1.61 as of Jul. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Aino Health AB (OSTO:AINO) Overvalued in 2026?
Based on GuruFocus' analysis, Aino Health AB stock appears to be overvalued.
The current stock price of kr0.19 is trading 48.5% above its estimated GF Value™ of kr0.13.
GuruFocus considers Aino Health AB to be Significantly Overvalued.
Key valuation signals for OSTO:AINO:
PS Ratio: 1.61 (30% above median its 10-year median of 1.24)
GF Value™: kr0.13 vs. price of kr0.19 (48.5% above fair value)
Industry Position: 9.5% above the Healthcare Providers & Services median (#343 of 659)
No single metric tells the full story. See the OSTO:AINO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Aino Health AB provides corporate health management solutions. The company has developed a complete system of IT-based services with a focus on improving corporate health and reducing sickness absence levels in private and public organizations. Its solution consists of HealthManager, HealthDesk, and Consulting services. Company SaaS platform combines advance data analytics, research-based insights, and AI to empower leaders to unlock the full potential of their teams and to foster a healthier, more sustainable work environment.
26GF Score
Get the complete analysis for OSTO:AINO
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:AINO has been successfully added to your 
